#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prostate cancer Anal fistula Heritable pulmonary arterial hypertension Chondrosarcoma Meningitis meningococcal Juvenile chronic myelomonocytic leukaemia Emphysema Deafness Synovial sarcoma recurrent Rectal cancer Pancreatic carcinoma metastatic Cystic fibrosis gastrointestinal disease Adult T-cell lymphoma/leukaemia refractory Prodromal Alzheimer's disease Ovarian cancer More trials…

    Learn about Rare Diseases

    Idiopathic pulmonary fibrosis – Basic Information Synovial sarcoma – Life with Disease Antithrombin III deficiency – Basic Information Mantle cell lymphoma stage II – Life with Disease Haemophilia A with anti factor VIII – Basic Information Advanced systemic mastocytosis Ehlers-Danlos syndrome – Basic Information Extranodal marginal zone B-cell lymphoma (MALT type) – Diagnostics Prader-Willi syndrome – Diagnostics Waldenstrom’s macroglobulinaemia recurrent – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ursodeoxycholic Acid Mva-Hbvac SELTOREXANT Testosterone Undecanoate Ibuprofen Arginine Calcium Chloride Dihydrate Doconexent Dexamethasone Isonicotinate Syn321 Topotecan Hydrochloride Setanaxib AZD4360 Travoprost Gliclazide Anhydrous Cholestyramine HUPERZINE A Cetirizine Dihydrochloride Sirolimus Xtmab-16 Trimethoprim More therapies…

    Learn about Your Condition

    Amnestic disorder Respiratory failure Testicular germ cell cancer Appendicitis Subarachnoid haemorrhage Intermittent claudication Pathogen resistance Squamous cell carcinoma Metastases to lymph nodes Thermal burn Facial paresis Ovarian granulosa cell tumour Right ventricular dysfunction Pleomorphic liposarcoma Glioma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study of Ivosidenib and Azacitidine for Patients Aged 18 and Older with Untreated Acute Myeloid Leukemia with IDH1 Mutation

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Ivosidenib
    • Azacitidine
    France Germany Italy Poland Spain

  • Study of Brentuximab Vedotin Combined with R-DHAP Chemotherapy for Patients with Relapsed or Treatment-Resistant CD30-Positive Diffuse Large B-Cell Lymphoma Who Are Eligible for Stem Cell Transplant

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-Hodgkin’s lymphoma
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Brentuximab Vedotin
    Belgium The Netherlands Spain

  • Study comparing dexamethasone versus immunoglobulin plus prednisone for adults with immune thrombocytopenia (ITP) who have moderate to severe bleeding

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • Human Normal Immunoglobulin (Iv)
    • Dexamethasone
    • Prednisolone
    France

  • Study on Prednisone and Vitamin D for Elderly Patients with Diffuse Large B-Cell Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Glycerol
    • Colecalciferol
    • Prednisolone
    Italy

  • Study of Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Isatuximab
    • Bortezomib
    • Dexamethasone
    France

  • Study on Iberdomide and Dexamethasone, Alone or with Drug Combination, for Newly Diagnosed Multiple Myeloma Patients Not Eligible for Transplant

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Daratumumab
    • Iberdomide
    Spain
Previous Page
1 … 62 63 64 65 66 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!